Status | Study |
NOT_YET_RECRUITING |
Study Name: Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy Condition: Biliary Atresia Date: 2023-11-02 Interventions: OCA will be administered. |
RECRUITING |
Study Name: Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure Condition: Date: 2023-06-08 Interventions: All KPs were performed by a medical team.This technique involved creation of a 35-40 cm Roux loop to facilitate biliary drainage.After dis |
RECRUITING |
Study Name: Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure Condition: Date: 2023-06-08 Interventions: All KPs were performed by a medical team.This technique involved creation of a 35-40 cm Roux loop to facilitate biliary drainage.After dis |
Completed |
Study Name: Autologous BMNC Infusion for Liver Cirrhosis in Children With BA Condition: Biliary Atresia Date: 2022-08-22 Interventions: Interventional |
RECRUITING |
Study Name: Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia Condition: Biliary Atresia Date: 2019-08-13 Interventions: G-CSF is a glycoprotein produced by monocytes, fibroblasts, and endothelial cells.Filgrastim is a human granulocyte colony stimulating factor (G |
NOT_YET_RECRUITING |
Study Name: Intestinal Microbiome Composition in Infants With Biliary Atresia (BA) Condition: Biliary Atresia Date: 2019-01-30 |
COMPLETED |
Study Name: N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy Condition: Biliary Atresia Date: 2018-04-04 Interventions: Intravenous NAC therapy (6.25 mg/kg/hour of 10 mg/ml solution, or 0.625 ml/kg/hour, to give 150 mg/kg/day), startin |
Not yet recruiting |
Study Name: Transfusion Strategies for Pediatric Liver Transplantation Condition: Biliary Atresia Intrahepatic Syndromic Form Date: 2016-10-25 Interventions: Other: restrictive transfusion |
Enrolling by invitation |
Study Name: FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol Condition: Biliary Atresia Alagille Syndrome Date: 2016-09-20 Interventions: Other: Liver Stiffness Measurement (LSM) LSM will be measured via transient elastography utilizing the n |
Completed |
Study Name: the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia Condition: to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients. Date: 2016-07-26 |